Zentalis Pharmaceuticals (ZNTL) Stock Highlights

3 | +2.39%

2024-12-21 06:03:43

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Statistics

Range Today

2.89 3.1

Volume Today 1.85M

Range 1 Year

2.66 18.07

Volume 1 Year 325.86M

Range 3 Year

2.66 85.95

Volume 3 Year 677.41M

Range 10 Year

2.66 87.19

Volume 10 Year 793.51M

Highlights

Market Capitalization 281.59M (small)

Floating Shares 50.96M

Current Price 3

Price To Earnings -1.41

Price To Revenue -2.48

Price To Book 0.74

Earnings Per Share -2.74

Payout Ratio 0%

Performance

Latest +2.39%

1 Month -0.33%

3 Months -30.23%

6 Months -30.39%

1 Year -78.74%

3 Years -96.2%

5 Years -88%

10 Years -88%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.